Cymabay Therapeutics Inc. (CBAY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

10,300,000 $32,033 0.58%
2.
Commodore Capital

Egen Atkinson And Michael Kramarz

5,738,500 $17,847 +6% 3.98%
3.
Millennium Management

Israel Englander

2,372,700 $7,379 +15% 0%
4.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,170,464 $6,750 0.03%
5.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,893,997 $5,890 -6% 0.26%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.95 51,301 Officer, Director 171,301 2022-06-06 Filing
$3.04 20,000 Officer 20,000 2022-01-19 Filing
$4.30 5,000 Officer, Director 120,000 2019-10-10 Filing
$5.55 3,100 Officer, Director 115,000 2019-09-23 Filing
$5.50 1,900 Officer, Director 111,900 2019-09-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.02 11,675 Director 0 2019-02-07 Filing
$7.43 53,492 Director 131,036 2018-12-18 Filing
$8.17 88,889 Director 184,528 2018-12-17 Filing
$13.00 5,000 Officer 0 2018-08-29 Filing
$12.51 920 Director 18,316 2018-06-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 455,265 $1,343 0%
2. 263,529 $778 0.1%
3. 262,404 $774 0%
4. 210,000 $620 0.65%
5. 145,913 $430 0%
News See All